We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest

By MedImaging International staff writers
Posted on 04 Jul 2025
Image: A contrast-enhanced cardiac MRI of a patient with hypertrophic cardiomyopathy deemed by MAARS to be at high risk for sudden death (Photo courtesy of Johns Hopkins University)
Image: A contrast-enhanced cardiac MRI of a patient with hypertrophic cardiomyopathy deemed by MAARS to be at high risk for sudden death (Photo courtesy of Johns Hopkins University)

Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some are at a significantly increased risk of fatal cardiac events. Identifying which patients are at high risk has long been a challenge, with current clinical guidelines in the U.S. and Europe proving to be only about 50% accurate, no better than a coin toss. This has led to critical under-protection for high-risk individuals and unnecessary implantation of defibrillators in others. A new approach that can better identify at-risk patients and reduce unneeded interventions has now been developed and tested with significantly higher accuracy.

Researchers at Johns Hopkins University (Baltimore, MD, USA) have developed a deep learning-based artificial intelligence model called Multimodal AI for Ventricular Arrhythmia Risk Stratification (MAARS). The system was designed to analyze a full range of patient medical records in combination with contrast-enhanced MRI images of the heart. Unlike traditional methods, MAARS can interpret complex scarring patterns—fibrosis—found in the hearts of patients with hypertrophic cardiomyopathy, which are known to raise the risk of sudden cardiac death. While clinicians have struggled to make sense of this imaging data, the AI model was able to extract and utilize hidden predictive information from the scans. By doing so, the model not only predicts a patient’s risk but also explains the reasoning behind the assessment, enabling doctors to tailor personalized care plans. MAARS builds upon prior work from the same team that developed an AI model in 2022 for predicting cardiac arrest in infarct patients.

The researchers tested the new model on real-world data from patients treated at Johns Hopkins Hospital and Sanger Heart & Vascular Institute. The study, published in Nature Cardiovascular Research, showed that the AI model achieved 89% accuracy overall and 93% accuracy for patients aged 40–60, the demographic at highest risk. The tool significantly outperformed current clinical guidelines across all demographics. Beyond improving survival prediction, the model offers transparency in its decision-making process, a feature that enhances clinical trust and utility. The team now plans to validate MAARS on larger populations and adapt it for use with other heart conditions, such as cardiac sarcoidosis and arrhythmogenic right ventricular cardiomyopathy.

“Currently we have patients dying in the prime of their life because they aren’t protected and others who are putting up with defibrillators for the rest of their lives with no benefit,” said senior author Natalia Trayanova, a researcher focused on using AI in cardiology. “We have the ability to predict with very high accuracy whether a patient is at very high risk for sudden cardiac death or not.”

Related Links:
Johns Hopkins Hospital and Sanger Heart & Vascular Institute

Ultrasound Table
Women’s Ultrasound EA Table
Multi-Use Ultrasound Table
Clinton
New
Diagnostic Ultrasound System
DC-80A
New
Half Apron
Demi

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.